Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $185.52 million. The enterprise value is $280.09 million.

Market Cap	185.52M
Enterprise Value	280.09M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

MCRB has 151.45 million shares outstanding. The number of shares has increased by 16.08% in one year.

Shares Outstanding	151.45M
Shares Change (YoY)	+16.08%
Shares Change (QoQ)	+12.28%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	56.71%
Float	119.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.46
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.68

Current Ratio	1.68
Quick Ratio	1.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.40%
Return on Capital (ROIC)	-49.86%
Revenue Per Employee	$544,408
Profits Per Employee	-$354,863
Employee Count	233
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.05% in the last 52 weeks. The beta is 1.96, so MCRB's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	-74.05%
50-Day Moving Average	0.91
200-Day Moving Average	1.07
Relative Strength Index (RSI)	61.71
Average Volume (20 Days)	4,518,710

Short Selling Information

The latest short interest is 20.69 million, so 13.66% of the outstanding shares have been sold short.

Short Interest	20.69M
Short Previous Month	22.85M
Short % of Shares Out	13.66%
Short % of Float	17.30%
Short Ratio (days to cover)	4.48

Income Statement

In the last 12 months, MCRB had revenue of $126.85 million and -$82.68 million in losses. Loss per share was -$0.60.

Revenue	126.85M
Gross Profit	126.85M
Operating Income	-77.00M
Pretax Income	-82.68M
Net Income	-82.68M
EBITDA	-51.20M
EBIT	-66.79M
Loss Per Share	-$0.60

Full Income Statement

Balance Sheet

The company has $119.61 million in cash and $214.18 million in debt, giving a net cash position of -$94.57 million or -$0.62 per share.

Cash & Cash Equivalents	119.61M
Total Debt	214.18M
Net Cash	-94.57M
Net Cash Per Share	-$0.62
Equity (Book Value)	-59.74M
Book Value Per Share	-0.39
Working Capital	66.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$76.01 million and capital expenditures -$3.97 million, giving a free cash flow of -$79.98 million.

Operating Cash Flow	-76.01M
Capital Expenditures	-3.97M
Free Cash Flow	-79.98M
FCF Per Share	-$0.55

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -60.70% and -65.18%.

Gross Margin	100.00%
Operating Margin	-60.70%
Pretax Margin	-65.18%
Profit Margin	-65.18%
EBITDA Margin	-40.36%
EBIT Margin	-52.66%
FCF Margin	-63.05%

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.08%
Shareholder Yield	-16.08%
Earnings Yield	-44.57%
FCF Yield	-43.11%

Analyst Forecast

The average price target for MCRB is $5.75, which is 369.39% higher than the current price. The consensus rating is "Buy".

Price Target	$5.75
Price Target Difference	369.39%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	21.92%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MCRB has an Altman Z-Score of -3.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.94
Piotroski F-Score	2